Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials).
Rudenko, Larisa
Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials). [electronic resource] - Influenza and other respiratory viruses Nov 2008 - 203-9 p. digital
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1750-2659
10.1111/j.1750-2659.2008.00064.x doi
Administration, Intranasal
Antibodies, Viral--blood
Cross Reactions
Hemagglutination Inhibition Tests
Humans
Immunization, Secondary
Immunoglobulin A--analysis
Influenza A Virus, H2N2 Subtype--genetics
Influenza A Virus, H5N1 Subtype--immunology
Influenza A Virus, H5N2 Subtype--genetics
Influenza Vaccines--administration & dosage
Influenza, Human--prevention & control
Nasal Mucosa--immunology
Neutralization Tests
Reassortant Viruses--genetics
Russia
Vaccines, Attenuated--administration & dosage
Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials). [electronic resource] - Influenza and other respiratory viruses Nov 2008 - 203-9 p. digital
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1750-2659
10.1111/j.1750-2659.2008.00064.x doi
Administration, Intranasal
Antibodies, Viral--blood
Cross Reactions
Hemagglutination Inhibition Tests
Humans
Immunization, Secondary
Immunoglobulin A--analysis
Influenza A Virus, H2N2 Subtype--genetics
Influenza A Virus, H5N1 Subtype--immunology
Influenza A Virus, H5N2 Subtype--genetics
Influenza Vaccines--administration & dosage
Influenza, Human--prevention & control
Nasal Mucosa--immunology
Neutralization Tests
Reassortant Viruses--genetics
Russia
Vaccines, Attenuated--administration & dosage